Medical News

RSS

Navidea commences enrollment in [18F]NAV4694 Phase 2 study for Alzheimer's

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that enrollment has commenced at two sites participating in its Phase 2, open-label, safety and efficacy PET imaging study of [18F]NAV4694 for detection of cerebral β-amyloid plaque in subjects diagnosed with probable Alzheimer's disease (AD).

19 Sep 2012

Many women undertreat pelvic floor disorders and suffer in silence

New research issued by the PFD Alliance finds that 90 percent of Americans underestimate or are unsure about the prevalence of pelvic floor disorders (PFDs) which will impact one in three women at some point during their lives. This means many women undertreat PFDs and suffer in silence.

19 Sep 2012

Xenex's pulsed xenon UV more effective than bleach in decontaminating C. diff surfaces

Healthcare associated infections (also referred to as HAIs or hospital acquired infections) are the fourth leading cause of death in the United States, costing more than $30 billion each year. Evidence continues to mount that hospital cleanliness plays a role in the spread of HAIs, which are caused by deadly pathogens such as C. diff, MRSA, VRE and Acinetobacter.

19 Sep 2012

UC San Diego’s bold plan aims to personalize cancer treatment

UC San Diego Moores Cancer Center launched a bold plan today aimed at personalizing cancer treatment. The "My Answer to Cancer" team of oncologists, bioinformaticians, pathologists and geneticists pledges to "sequence" or analyze the DNA of large numbers of patients with cancer in order to match each patient to the best available drug for his or her particular tumor.

19 Sep 2012

BPA exposure not likely to cause obesity, finds study

The American Chemistry Council (ACC) issued the following statement in response to an article in the Journal of the American Medical Association (JAMA) by Leonardo Trasande, M.D., New York University, et al, and scheduled to be discussed at a media briefing on Tuesday, September 18.

19 Sep 2012

Rainbow Biosciences explores NASA technology to produce adult stem cells for medical research

Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.

19 Sep 2012

Illumina launches new RNA sequencing kits

Illumina today introduced TruSeq Stranded mRNA and Total RNA Sample Preparation Kits for RNA sequencing. The new reagent kits enable researchers to quickly and easily conduct gene expression studies that provide a complete view of the transcriptome, even from low-quality RNA samples, such as formalin-fixed, paraffin-embedded (FFPE) samples.

From Illumina, Inc. 19 Sep 2012

First Edition: September 19, 2012

Today's headlines include a series of reports detailing who makes up Romney's so-called "47 percent" who get tax breaks and what federal assistance they receive -- whether it is Medicare, Medicaid or another entitlement program.

19 Sep 2012

U-Systems receives FDA approval for somo-v ABUS

The U.S. Food and Drug Administration today approved the first ultrasound device for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.

19 Sep 2012

Friendly bacteria: do we really need to eat probiotic yogurts?

According to the World Health Organization (WHO) probiotics are “live microorganisms which when administered in adequate amounts confer a health benefit on the host”.

19 Sep 2012

Tranexamic acid: an interview with Prof Ian Roberts

Tranexamic acid is a medicine that reduces blood clot breakdown. In this way it helps in patients with bleeding.

19 Sep 2012

Mental illness campaign launched by Australia’s private hospitals sector

Australia’s private hospitals sector is set to test just how much Australians really know about some of the nation’s most prevalent mental disorders with the launch of its large-scale campaign, ‘What do you know…. about mental illness?’

19 Sep 2012

Pediatric clearance for K2M’s treatment of adolescent idiopathic scoliosis

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced that it has received an additional clearance to treat adolescent idiopathic scoliosis.

18 Sep 2012

Measures of kidney function may be linked to thrombosis

Estimated glomerular filtration rate and albumin-creatinine ratio are independently associated with venous thromboembolism, research suggests.

18 Sep 2012

Diabetes risk accumulates with visceral fat

A change in intraabdominal fat area over time is associated with the development of diabetes in Japanese-American individuals, report US researchers.

18 Sep 2012

Most women with heart disease can shun advice to avoid pregnancy

The majority of women with structural or ischemic heart disease can safely undergo pregnancy with extensive pre-evaluation and high-quality care, say researchers.

18 Sep 2012

US and Dutch views differ on sedation at end of life

Physicians from the USA and the Netherlands differ in their views on sedation at the end of life, with the Dutch justifying it by stating that it does not hasten death, and the Americans indicating that although it might hasten death, this is justifiable if it is not the primary intention, show study findings.

18 Sep 2012